News For Gilead Sciences


This RSS feed URL is deprecated

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Google 17/07/2018 05:37:35

Holowesko Partners LTD Decreased By $20.10 Million Its Gilead Sciences (GILD) Position; Kulicke & Soffa Industries ... - Hillary HQ (press release)


Holowesko Partners LTD Decreased By $20.10 Million Its Gilead Sciences (GILD) Position; Kulicke & Soffa Industries ...
Hillary HQ (press release)
Holowesko Partners Ltd decreased Gilead Sciences Inc (GILD) stake by 22% reported in 2018Q1 SEC filing. Holowesko Partners Ltd sold 268,000 shares as Gilead Sciences Inc (GILD)'s stock declined 17.62%. The Holowesko Partners Ltd holds 950,000 ...

and more »
Google 16/07/2018 17:23:55

Gilead Sciences Stock Ripe for a Pre-Earnings Options Trade - Schaeffers Research (blog)


Schaeffers Research (blog)

Gilead Sciences Stock Ripe for a Pre-Earnings Options Trade
Schaeffers Research (blog)
What's more, options on Gilead Sciences stock are relatively cheap at the moment, from a historical standpoint. The equity's Schaeffer's Volatility Index (SVI) was last seen at 28% -- in the 27th percentile of its annual range. In other words, short ...
Gilead Sciences to Release Second Quarter 2018 Financial Results on Wednesday, July 25, 2018Business Wire (press release)
As Gilead Sciences Com (GILD) Valuation Declined, Symphony Asset Management Has Upped Its Position; Cutter ...Hillary HQ (press release)
In which scenario Chubb Limited (CB) and Gilead Sciences, Inc. (GILD) are Trading Now?NMSU Nеws
Investopedia (blog) -StockNewsGazette -TopChronicle -Motley Fool
all 202 news articles »
Google 16/07/2018 16:52:18

Are We Paying Enough Attention to Gilead Sciences, Inc. (GILD), The Kraft Heinz Company (KHC) - Post Analyst


Post Analyst

Are We Paying Enough Attention to Gilead Sciences, Inc. (GILD), The Kraft Heinz Company (KHC)
Post Analyst
Gilead Sciences, Inc. (NASDAQ:GILD) enjoyed a weak run from the open in trading on 07/13/2018 with decreased volume coming into the shares and a close lower. Volume approached 4.03 million shares vs. average over the past 3 months of 7.24 million ...

and more »
Google 16/07/2018 12:29:00

4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit? - Motley Fool


Motley Fool

4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit?
Motley Fool
Gilead Sciences (NASDAQ:GILD) claimed three of these drugs, including No. 1 Genvoya. The other two top HIV drugs -- Triumeq and Tivicay -- belonged to GlaxoSmithKline (NYSE:GSK). But a game of musical chairs is on the way that could shake up the HIV ...
Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At RiskCalifornia Healthline

all 2 news articles »
Google 16/07/2018 12:02:00

Gilead: Cheap Valuation For Great Pipeline - Seeking Alpha


Gilead: Cheap Valuation For Great Pipeline
Seeking Alpha
The company is trading at a cheap valuation, especially for biotech with a robust pipeline. There was a large spread between management and analyst sentiment during the Q1 earnings call, which presents a buying opportunity. Gilead is rounding out their ...

Google 12/07/2018 16:58:00


Gilead: Laddered Calls - Seeking Alpha


Gilead: Laddered Calls
Seeking Alpha
Gilead Pharmaceuticals (NASDAQ:GILD) has been the subject of many posts in this blog because it is a very good Dividend Machine stock. The best Dividend Machine stocks deliver dividends, dividend increases, and provide covered call opportunities.

Google 11/07/2018 00:29:00

 1 2